PFPedro Smith Pereira Ferraro

Pedro Smith Pereira Ferraro

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Pedro Smith Pereira Ferraro has a total of 21 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Unveiling the genomic and phenotypic landscape of Acinetobacter species from different environmental sources in Brazil

    by Amanda Yaeko Yamada, Anna Luiza Bauer Canellas, Matheus Nunes Diniz, Pedro Smith Pereira Ferraro, Daniel de Sena Miranda, Ana Beatriz Nascimento Costa, Marlon Benedito Nascimento Santos, Karoline Rodrigues Campos, Claudio Tavares Sacchi, Beatriz Balthazar Abdon, et al.

    This study aimed to investigate the diversity of Acinetobacter spp. isolated from aquatic environments along the Brazilian coast, with a focus on environmental reservoirs of clinically relevant resistance genes. Twenty-three Acinetobacter isolates were recovered from marine animals, floating plastic, and surface water samples collected in two contrasting Brazilian regions: the heavily polluted Guanabara Bay (Rio de Janeiro) and the pristine Fernando de Noronha Archipelago (Pernambuco). Seven species were identified, with A. venetianus (n = 13) and A. johnsonii (n = 4) being the most frequent. Two A. johnsonii isolates carried the metallo-β-lactamase gene blaNDM-1, along with resistance to fluoroquinolones and carbapenems. Resistance to polymyxins and aminoglycosides was also observed in A. haemolyticus, A. baumannii, and A. modestus. ApaI-PFGE dendrogram and phylogenetic analyses based on single nucleotide position (SNPs) revealed high genetic diversity, and global comparisons placed the environmental isolates in lineages distinct from those commonly associated with healthcare-associated infections. This study highlights the diversity of Acinetobacter spp. in aquatic environments and their potential role as reservoirs of clinically important resistance genes, including blaNDM-1. By uncovering resistance mechanisms in environmental Acinetobacter strains, this work reinforces the relevance of environmental surveillance for One Health initiatives, particularly in regions with significant anthropogenic impact.

  • Open Access

    Genomics and Antimicrobial Susceptibility of Clinical Pseudomonas aeruginosa Isolates from Hospitals in Brazil

    by Carlos Henrique Camargo, Amanda Yaeko Yamada, Andreia Rodrigues de Souza, Marisa de Jesus de Castro Lima, Marcos Paulo Vieira Cunha, Pedro Smith Pereira Ferraro, Claudio Tavares Sacchi, Marlon Benedito Nascimento dos Santos, Karoline Rodrigues Campos, Monique Ribeiro Tiba-Casas, et al.

    Pseudomonas aeruginosa, an opportunistic pathogen causing infections in immunocompromised patients, usually shows pronounced antimicrobial resistance. In recent years, the frequency of carbapenemases in P. aeruginosa has decreased, which allows use of new beta-lactams/combinations in antimicrobial therapy. Therefore, the in vitro evaluation of these drugs in contemporary isolates is warranted. We evaluated the antimicrobial susceptibility and genomic aspects of 119 clinical P. aeruginosa isolates from 24 different hospitals in Brazil in 2021–2022. Identification was performed via MALDI-TOF-MS, and antimicrobial susceptibility was identified through broth microdilution, gradient tests, or disk diffusion. Whole-genome sequencing was carried out using NextSeq equipment. The most active drug was cefiderocol (100%), followed by ceftazidime–avibactam (94.1%), ceftolozane–tazobactam (92.4%), and imipenem–relebactam (81.5%). Imipenem susceptibility was detected in 59 isolates (49.6%), and the most active aminoglycoside was tobramycin, to which 99 (83.2%) isolates were susceptible. Seventy-one different sequence types (STs) were detected, including twelve new STs described herein. The acquired resistance genes blaCTX-M-2 and blaKPC-2 were identified in ten (8.4%) and two (1.7%) isolates, respectively. Several virulence genes (exoSTUY, toxA, aprA, lasA/B, plcH) were also identified. We found that new antimicrobials are effective against the diverse P. aeruginosa population that has been circulating in Brazilian hospitals in recent years.